Light Mode
$3.59 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.59, $0.13 below the day’s high of $3.72
-0.91 (-20.22%) / 6M
Momentum, market sentiment, and recent alerts
TLSI reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -28.5%.
No alerts for TLSI in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020 and is headquartered in Westminster, CO.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.